PLOS
open access
CC0 1.0
A genomic-led strategy to anticipate drug safety effects
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor#829266
- From toxicogenomics to predictive toxicology and exposomics: defining the next decade of gene-environment research.#427650
- Pharmacogenomic Inequalities: Strategies for Justice in Biomedical Research and Healthcare#719096
- Interpretable neural network for risk stratification and drug target discovery based on PBMC transcriptomes.#30538
- The re-emergence of natural products for drug discovery in the genomics era#335722
Record · ID 376014
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive